ATRA (Atara Biotherapeutics) Float Percentage Of Total Shares Outstanding: 70.19% (As of Jun. 29, 2026)


ATRA Atara Biotherapeutics Inc ATRA
29 GF Score
Price $11.17
GF Value $1.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Atara Biotherapeutics Float Percentage Of Total Shares Outstanding?

Atara Biotherapeutics ATRA +6.94% 29 Float Percentage Of Total Shares Outstanding is 70.19% as of Jun. 29, 2026. GuruFocus rates ATRA with a GF Score™ of 29/100 and a GF Value™ of $1.56 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Atara Biotherapeutics's float shares is 6.32 Mil. Atara Biotherapeutics's total shares outstanding is 9.01 Mil. Atara Biotherapeutics's float percentage of total shares outstanding is 70.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Atara Biotherapeutics's Insider Ownership is 43.93%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Atara Biotherapeutics's Institutional Ownership is 32.78%.

ATRA
29GF Score
Atara Biotherapeutics Inc ATRA
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atara Biotherapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Atara Biotherapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=6.32/9.01
=70.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 70.19% mean?
Atara Biotherapeutics (ATRA) has a Float Percentage Of Total Shares Outstanding of 70.19% as of Jun. 29, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Atara Biotherapeutics and its competitors.
Is Atara Biotherapeutics' Float Percentage Of Total Shares Outstanding too high?
Atara Biotherapeutics' current Float Percentage Of Total Shares Outstanding is 70.19%. Overall, Atara Biotherapeutics has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Atara Biotherapeutics' Float Percentage Of Total Shares Outstanding compare to ANIX and BMEA?
Atara Biotherapeutics' Float Percentage Of Total Shares Outstanding of 70.19% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Atara Biotherapeutics and its competitors. Atara Biotherapeutics's current Float Percentage Of Total Shares Outstanding is 70.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atara Biotherapeutics stock overvalued right now?
Based on GuruFocus' analysis, Atara Biotherapeutics (ATRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.56, compared to a current price of $11.17 — trading 616% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 70.19%. Atara Biotherapeutics' overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Atara Biotherapeutics (ATRA), the current Float Percentage Of Total Shares Outstanding is 70.19% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atara Biotherapeutics (ATRA) Overvalued in 2026?

Based on GuruFocus' analysis, Atara Biotherapeutics stock appears to be overvalued. The current stock price of $11.17 is trading 616% above its estimated GF Value™ of $1.56. GuruFocus considers Atara Biotherapeutics to be Significantly Overvalued.

Key valuation signals for ATRA:

  • Float Percentage Of Total Shares Outstanding: 70.19%
  • GF Value™: $1.56 vs. price of $11.17 (616% above fair value)
  • GF Score™: 29/100 with 7 warning signs

No single metric tells the full story. See the ATRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atara Biotherapeutics Business Description

Other Exchanges 0HIY:UKAT20:Germany
Address 1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
29GF Score

Get the complete analysis for ATRA

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.17
Price
$1.56
GF Value